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 Abstract
Background: Baker's asthma (BA) is the most prevalent occupational respiratory disease in developed countries. It is caused by inhalation 
of wheat dust in the working environment and affects 1%-10% of workers in the baking industry. Diagnosis of BA is based on bronchial 
challenge with wheat, a technique that carries a high risk for patients. The wheat lipid transfer protein Tri a 14 is a major allergen in BA. 
Objective: The aim of our study was to characterize Tri a 14 as a marker of BA in order to prevent patients from having to undergo bronchial 
challenge with wheat.
Methods: The study population comprised 55 patients selected at the Rio Hortega Hospital, Valladolid, Spain. Patients with BA were 
diagnosed using a skin prick test (SPT) with wheat and Tri a 14 and bronchial challenge test (BCT) with wheat. Patients with food allergy 
had a clear clinical history of allergy to peach confirmed by positive SPT to peach extract and Pru p 3. 
Results: All patients in the BA group had a positive SPT result with wheat (100%), and most had positive results with Tri a 14 (95%). A 
positive BCT result with Tri a 14 was also observed in 22 of 27 of the patients with BA (82%). The response to Tri a 14 was specifically 
associated with BA.
Conclusion: Tri a 14 is a good marker of BA and can be used in SPT and BCT as an alternative diagnostic method, thus avoiding bronchial 
challenge with wheat and reducing the risk associated with this technique.
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 Resumen
Antecedentes: El asma del panadero (BA) es la enfermedad respiratoria ocupacional más frecuente en los países occidentales. Está 
causada por la inhalación diaria de harina de trigo en el entorno de trabajo, afectando entre 1-10% de los trabajadores de la industria 
panadera. El diagnóstico de BA se basa en la provocación bronquial con trigo, una técnica de alto riesgo para los pacientes. La proteína 
de transferencia de lípidos de trigo (LTP) Tri a 14 ha sido descrita como alérgeno principal en esta patología.
Objetivo: El objetivo de nuestro estudio ha sido caracterizar Tri a 14 como marcador de BA, y así evitar la provocación bronquial con trigo 
en estos pacientes. 
Métodos: Para ello, se seleccionaron cincuenta y cinco pacientes en el Hospital Río Hortega de Valladolid, España. 
Resultados: Los pacientes diagnosticados con BA mostraron prueba cutánea (SPT) positiva a trigo (100%) y la mayoría también a Tri a 14 
(95%). Todos ellos, fueron sometidos a provocación bronquial con Tri a 14, observándose un resultado positivo en 22/27 de los sujetos 
evaluados (82%). 
Conclusiones: En base a esto, se puede concluir que Tri a 14 es un buen marcador de BA, y podría ser utilizado en SPT y provocación 
bronquial como método diagnóstico, reduciendo el uso de la provocación bronquial con trigo y el riesgo asociado a esta técnica.
Palabras clave: Asma del panadero. Proteína de transferencia de lípidos. Alérgeno marcador. Tri a14. Diagnóstico de alergia. LTP.
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Introduction
Occupational asthma causes more than 10% of all cases of 
asthma in adults, and baker's asthma (BA) is the most prevalent 
occupational respiratory disease in Western countries [1]. BA 
is a complex disease induced by inhalation of wheat dust in 
the working environment. It affects approximately 1%-10% 
of workers in the baking industry [2]. Many workers in the 
milling, baking, and food processing industries are exposed to 
wheat dust in the atmosphere and are therefore at high risk of 
developing respiratory allergy. However, this allergy is often 
misdiagnosed, with significant legal, economic, and health 
consequences for affected patients [3]. 
Current methods for the diagnosis of BA are limited. 
Bronchial challenge test (BCT) is considered the gold standard, 
although it can only be performed in centers with specialized 
equipment and trained personnel and is potentially dangerous 
for the patient [1]. In vitro testing (specific IgE assays) has poor 
predictability and specificity, possibly because of insufficient 
purity of the wheat extracts used or the absence of all major 
allergens in the extracts [3,4]. The basophil activation test has 
been proposed as a reliable in vitro technique for diagnosis of 
immediate food allergy (FA) to wheat in children [4], although 
it is not widely used for diagnosis of BA. 
In recent years, some authors have aimed to design a 
panel of wheat allergens for diagnosis of patients with BA 
that would obviate specific bronchial challenge [5,6]. Over 
30 wheat allergens have been associated with BA, and many 
have also been implicated in food allergy [7]. The introduction 
of microarray techniques featuring a large panel of purified 
allergens has proven a major advance in the diagnosis of 
allergic diseases [8]. We previously applied this approach in 
the diagnosis of patients with BA [9] and found that Tri a 14 
was recognized only by patients with BA, but not by those 
diagnosed with wheat allergy.
The wheat lipid transfer protein (LTP) Tri a 14 is a major 
allergen in BA [10,11]. Tri a 14 belongs to a plant LTP family 
that has been extensively shown to include food allergens. In 
the case of BA, 45% of Spanish patients had a positive skin 
prick test (SPT) result to Pru p 3, although most could consume 
peach without experiencing symptoms [12]. These results point 
to primary sensitization through wheat dust inhalation, followed 
by development of allergy after oral intake due to cross-reactivity 
between Pru p 3 and Tri a 14. An analysis of the molecular basis 
of the cross-reactivity between peach and wheat revealed an 
overlapping IgE-binding region in both proteins [13].
The aim of our study was to characterize Tri a 14 as a 
marker of BA in order to prevent patients from having to 
undergo bronchial challenge with wheat. The response to Tri 
a 14 was compared with that of patients with FA.
Methods
Study Population
Two groups of patients were selected at Rio Hortega 
Hospital in Valladolid, Spain. Patients in the BA group (patients 
1 to 37, Table) had to have a convincing clinical history of 
wheat-induced respiratory allergy, a positive response in the 
SPT, and positive result in a BCT with wheat. Patients in 
the FA group (patients 1 to 18, Table) had to have a clinical 
history of peach allergy and positive SPT result with peach 
extract (ALK-Abelló). These patients also had to have 1 of 
the following: oral allergy syndrome, urticaria-angioedema, 
gastrointestinal symptoms (diarrhea, vomiting), and respiratory 
allergy (rhinitis-asthma) after ingestion of peach. 
Five nonallergic individuals were included as a control 
group for the BCT. No response was observed in this group. 
The Ethic Committees of the Technical University of Madrid 
and Rio Hortega Hospital in Valladolid approved the study. 
All patients and controls gave their written informed consent 
to participate.
Skin Prick Testing
SPT was performed according to standard procedures 
following the recommendations of the European Academy of 
Allergy and Clinical Immunology [14]. All patients underwent 
SPT using an in-house wheat extract (10 mM PBS, 0.5M 
NaCl, pH 7.4), a commercial peach extract (ALK-Abelló), 
and purified proteins (native and recombinant forms of Tri a 
14 and Pru p 3). SPT was performed by testing the wheat and 
peach extracts up to 1 mg/mL and the purified proteins up 
to 20 µg/mL [15]. One sterile device was used for each test. 
Histamine phosphate (10 mg/mL) and sterile 0.9% saline were 
used as positive and negative controls, respectively. A mean 
diameter ≥3 mm greater than the negative control 15 minutes 
after puncture was considered a positive result. The panel of 
common aeroallergens (ALK-Abelló) included grass pollen, 
olive tree pollen, dust mites, molds, and foods (nuts, barley, 
and fruits [kiwi, apple, peach]), and spices. 
Bronchial Challenge Testing
BCT was performed double blind as described by Palacin 
et al [10], with modifications [16,17]. An in-house wheat 
extract with a protein concentration of 5 mg/mL and fresh 
peach juice were used. Spirometry was performed following 
the recommendations of the American Thoracic Society/
European Respiratory Society [18]. Aerosolized particles 
generated using a continuous pressurized DeVilbiss 646 
nebulizer were inhaled for 2 minutes at a normal breathing 
volume, starting with control PBS and followed—at 10-minute 
intervals—by increasing concentrations of the extract. The 
dose was determined by end-point titration based on the first 
dilution with a positive SPT response. A positive response 
was defined as >20% fall from baseline in forced expiratory 
volume in the first second (FEV1). After specific BCT, hourly 
peak expiratory flow measurements were recorded for 9 hours. 
BCT was performed with the same extract in 5 healthy controls, 
all of whom had negative results.
To confirm peach allergy, oral challenge was performed with 
whole peach juice (skin plus pulp) freshly liquefied in a blender. 
The challenge began with a 1:100 dilution of the aliquot of juice 
that had generated a wheal measuring at least 3×3 mm2.
Wheat Extract
Whole seeds of bread wheat (Triticum aestivum, Astral 
cultivar) were ground, defatted with cold acetone (1:5 [wt/
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Table. Demographic and Clinical Data of Study Patients  
Patient   No. Age/Sex Symptoms   SPT (mm2)a   Oral Challengeb  Bronchial Challenge
   Wheat     Tri a 14    Peach  Pru p 3 Wheat  Peach Wheat Peach Tri a 14
BA1   37/M As 20 28 0 0 0 0 1 0 1
BA2   18/M As 78 0 78 68 1 ND 1 1 1
BA3   46/F As, An 82 84 42 48 1 ND 1 0 ND
BA4   31/F As, An 28 32 28 28 0 ND 1 0 ND
BA5   20/M As 38 28 0 0 0 0 1 0 1
BA6   46/M As 29 30 0 0 0 0 1 0 1
BA7   32/F As, U, OAS 36 26 0 0 0 0 1 0 1
BA8   56/M As 20 22 0 0 0 0 1 0 0
BA9   25/M As, U 20 24 0 0 0 0 1 0 1
BA10   18/M As, An 38 32 32 0 1 0 1 0 ND
BA11   25/F As 28 26 0 0 0 0 1 0 1
BA12   22/M As, An 23 24 0 0 1 0 1 0 ND
BA13   41/M As, An 32 28 22 24 1 1 1 0 ND
BA14   34/M As 20 41 0 0 0 0 1 0 1
BA15   19/M An 24 22 62 60 1 1 1 1 ND
BA16   28/M As 42 32 34 28 1 1 1 1 1
BA17   41/M An 38 28 32 28 1 ND 1 1 ND
BA18 19/F An 24 24 62 60 1 ND 1 1 ND
BA19 35/F An 36 32 42 46 1 1 1 1 ND
BA20 27/M As 24 24 0 0 0 0 1 0 1
BA21 19/M As 32 32 0 0 0 0 1 0 1
BA22 40/M As 26 26 0 0 0 0 1 0 0
BA23 27/M Rh, As 22 26 0 0 0 0 1 0 0
BA24 36/M Rh, As 20 22 0 0 0 1 1 0 1
BA25 37/M As, U 42 42 0 20 0 0 1 0 1
BA26 38/M As 22 22 0 0 0 0 1 0 1
BA27 41/M As 24 0 0 0 0 0 1 0 1
BA28 65/M Rh, As 22 22 0 0 0 0 1 0 0
BA29 40/M Rh As 22 22 0 0 0 0 1 0 1
BA30 52/M As 32 32 0 0 0 0 1 0 1
BA31 34/M Rh, As 52 52 0 0 0 0 1 0 1
BA32 26/M As 34 34 0 0 0 0 1 0 0
BA33 41/M As 22 22 0 0 0 0 1 0 1
BA34 20/M As 32 32 0 0 0 0 1 0 ND
BA35 22/M As 26 26 0 0 0 0 1 0 1
BA36 41/M As 26 28 0 0 0 0 1 0 1
BA37 38/M As 28 28 0 0 0 0 1 0 1
FA1   22/F As 28 30 22 0 1 0 0 0 0
FA2   22/F As, An 42 46 48 29 1 1 0 0 ND
FA3   18/M An 0 42 38 32 0 ND 0 0 ND
FA4   18/F An 0 40 22 24 0 1 0 0 ND
FA5   25/F An 0 40 49 38 0 1 0 0 ND
FA6   21/F An 74 63 32 39 1 1 0 0 ND
FA7   20/M As, An 0 40 52 48 0 1 0 1 ND
FA8   20/F An 21 43 86 62 0 1 0 ND ND
FA9   24/M As 22 0 42 40 0 0 0 0 0
FA10 47/F An 0 0 43 46 0 1 0 0 0
FA11 22/M Rh, An 0 0 22 29 1 1 0 0 0
FA12 21/M A, U, OAS 22 0 20 22 1 ND 0 0 ND
FA13 20/M An 40 23 42 42 0 1 0 0 0
FA14 18/M U, OAS 0 0 22 22 0 1 0 0 0
FA15 18/M OAS 0 0 34 34 0 1 0 0 0
FA16 20/M OAS 0 0 22 22 0 1 0 0 0
FA17 23/F U, OAS 0 0 32 32 0 1 0 0 0
FA18 22/M U, OAS 0 0 24 25 0 1 0 0 ND
Abbreviations: An, anaphylaxis; As, asthma; BA, baker’s asthma; FA, food allergy; ND, not determined; OAS, oral allergy syndrome; Rh, rhinitis; SPT, skin 
prick test; U, urticaria.  
aArea ≥20 mm2 was considered positive. 
b1=positive; 0=negative. 
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of Tri a 14 in SPT and BCT was calculated using receiver 
operating characteristic (ROC) curves and analysis of the area 
under the curve (AUC). P<.05 was considered significant.
Results 
In addition to a positive BCT result with wheat, all BA 
patients in our study had a positive SPT result with wheat 
(100%) and most also had a positive result with Tri a 14 
(95%). We observed an association between BA and a positive 
response to Tri a 14 by SPT (χ2 test, 0.52; P<.0001). 
Similarly, a positive BCT result with Tri a 14 was observed 
in 22 of the 27 patients with a positive response to the BCT 
(82%). The results of both tests (SPT and BCT) were compared 
for each patient, and a strong correlation was observed 
(Pearson, 0.83; P<.0001). By contrast, most patients in this 
group had a negative response to peach in the oral challenge 
(only 5 positive results in 32 patients) to peach juice in the 
BCT (only 6 positive results in 37 patients) (Figure, A and B).
In contrast with the results for the BA patients, all patients 
in the FA group reacted to peach and Pru p 3 by SPT, although 
50% also had a positive response to Tri a 14 by SPT. Moreover, 
87.5% (14/16) of the patients who underwent oral challenge 
with peach experienced symptoms after the test. In the BCT, 
only 1 FA patient (6%) showed a positive result with peach but 
did not react to wheat or Tri a 14 (Figure, A and B). 
Receiver operating characteristic (ROC) curves were 
constructed to compare the SPT and BCT response to Tri a 14 
with the response to wheat to determine the validity of Tri a 
14 as a diagnostic tool in BA. The area under the curve (AUC) 
was 0.5201 for SPT and 0.5926 for BCT. The values obtained 
are within the reference range. Thus, Tri a 14 seemed to be a 
specific marker of BA in the BCT.
Discussion
Occupational allergic respiratory disorders such as BA 
are often misdiagnosed, with significant legal, economic, 
and health consequences for affected patients [1,3]. BA is the 
leading cause of occupational respiratory disease in developed 
vol] for 1 hour at 4ºC), and, after drying, extracted with 0.1 
mol/L Tris-HCl (pH 7.5) and 10 mmol/L EDTA (1:5 [wt/vol] 
for 1 hour at 4ºC). After centrifugation (9000g for 30 minutes 
at 4ºC), the supernatant was dialyzed against H2O (cutoff, 
3.5 kDa) and freeze-dried. This crude extract was used for the 
SPTs. The protein concentration was quantified according to 
the Bradford method [19].
Isolation and Characterization of Tri a 14
The wheat bran extract was fractionated by means of 
cation exchange chromatography on a Sep-Pak Accell Plus 
CM cartridge (Waters) using 10 mmol/L ammonium acetate 
(pH 6.8) as the equilibration buffer. The retained material, 
which was enriched in Tri a 14, was then eluted with 
ammonium acetate (50 mmol/L, pH 6.8), dialyzed, and freeze-
dried. This Tri a 14–enriched fraction was further separated 
by reverse-phase high-performance liquid chromatography on 
a Nucleosil 300-C4 column (Scharlau Science; 8×250 mm; 
particle size, 5 mm) and elution with a linear gradient of 
acetonitrile in 0.1% trifluoroacetic acid (10% to 100% in 150 
minutes; 1 mL/min). Chromatographic fractions containing Tri 
a 14 were located by immunodetection after SDS-PAGE with 
both antipeach LTP antibody and a serum pool from patients 
with BA. These fractions were then pooled and freeze-dried. 
Pru p 3 was purified as previously described [20]. The allergens 
isolated were quantified using a commercial bicinchoninic acid 
test (ThermoFisher Scientific). SDS-PAGE was performed on 
Bio-Rad Miniprotean III System gels (15% polyacrylamide), 
according to the method of Laemmli. Bands corresponding to 
Tri a 14 in bran and flour extracts were quantified using the 
GelDoc 2000 System and Quantity One software (both from 
BioRad). N-terminal amino acid sequencing was carried out 
using standard methods with an Applied Biosystems 477A 
gas-phase sequencer.
Statistical Analysis 
Differences in the frequencies of positive response were 
analyzed using contingency tables and the χ2 test. Quantitative 
variables (response to BCT vs SPT result in mm2) were 
compared using the Pearson correlation. The predictive value 
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countries [21]. It is caused by the inhalation of wheat flour 
allergens, which does not seem to be influenced by local 
environmental allergens (pollen), and appears to be associated 
with a specific allergen sensitization profile that is different 
from that observed in patients with wheat-induced food allergy. 
Our study was performed in central Spain, a region with 
large areas of grass crops. Tri a 14 was recognized by most 
BA patients (95% by SPT and 82% by BCT). In fact, Tri a 14 
has been specifically associated with respiratory allergy to 
wheat but not with FA to wheat [8]. In the case of FA, a high 
percentage (50%) of patients also showed a positive reaction to 
Tri a 14 in the SPT, possibly owing to cross-reactivity between 
Tri a 14 and Pru p 3, as described previously in FA [12]. By 
contrast, this high reactivity was not confirmed by oral and 
bronchial challenge testing. 
We previously found that >60% of Spanish BA patients 
from different regions reacted to Tri a 14 both in vitro and in 
vivo, regardless of local pollen distribution [9,12]. Similarly, 
in the Czech Republic, Sotkovsky et al [11] found that 64% 
of BA patients presented IgE binding to Tri a 14. These 
results indicated that Tri a 14 is a major allergen involved in 
the development of BA, in contrast to wheat FA, where Tri 
a 14 seems to have a minor role [9]. Curiously, in a recently 
published study [23] on nonceliac wheat-allergic children, 
none of the patients presented a positive response to Tri a 14. 
Similarly, <10% of adult patients with allergy to plant foods 
had a positive response to Tri a 14 [8].
In recent years, some studies have aimed to design a panel 
of wheat allergens for the diagnosis of patients with BA in 
order to avoid specific bronchial challenge with wheat owing 
to its potential risk and technical requirements. Sander et al 
[22] produced a panel of 17 recombinant allergens associated 
with BA. However, the frequencies of sensitization observed 
were low, and no major allergens were detected. Sotkovsky 
et al [11] studied the IgE binding of wheat allergens using 
natural forms. Gomez Casado et al [9] identified more than 
20 allergens, but only Tri a 14, Tri a TLP, and tritin were 
recognized by more than 50% of sensitized patients (64%, 
100%, and 100%, respectively). Consequently, these were 
considered major allergens. However, only Tri a 14 seemed 
to be BA-specific. 
The specificity of Tri a 14 as a diagnostic marker of BA has 
been demonstrated both in vitro and in vivo [9] In this study, 
Tri a 14 presented high sensitivity, as it was recognized by 
95% and 82% of BA patients in SPT and BCT, respectively. 
The predictive value of Tri a 14 as a marker of wheat-induced 
respiratory allergy was demonstrated by BCT, as described 
elsewhere [10].
Tri a 14 proved to be a good tool for the diagnosis of BA. 
Therefore, BCT with wheat could be avoided, at least in those 
patients who react to Tri a 14, thus reducing the problems 
associated with the use of complete extracts in the diagnosis 
of this disorder.
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